FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2611412596> ?p ?o ?g. }

• W2611412596 endingPage "1308" @default.
• W2611412596 startingPage "1295" @default.
• W2611412596 abstract "Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review Ross G Edgar,1,2 Mitesh Patel,3 Susan Bayliss,4 Diana Crossley,2,5 Elizabeth Sapey,2,5 Alice M Turner4,6 1Therapy Services, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; 2Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; 3Division of Primary Care, University of Nottingham, Nottingham, UK; 4Institute of Applied Health Research, University of Birmingham, Birmingham, UK; 5Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; 6Department of Respiratory Medicine, Heart of England NHS Foundation Trust, Birmingham, UK Background: Alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition predisposing individuals to chronic obstructive pulmonary disease (COPD). The treatment is generally extrapolated from COPD unrelated to AATD; however, most COPD trials exclude AATD patients; thus, this study sought to systematically review AATD-specific literature to assist evidence-based patient management.Methods: Standard review methodology was used with meta-analysis and narrative synthesis (PROSPERO-CRD42015019354). Eligible studies were those of any treatment used in severe AATD. Randomized controlled trials (RCTs) were the primary focus; however, case series and uncontrolled studies were eligible. All studies had ≥10 participants receiving treatment or usual care, with baseline and follow-up data (>3 months). Risk of bias was assessed appropriately according to study methodology.Results: In all, 7,296 studies were retrieved from searches; 52 trials with 5,632 participants met the inclusion criteria, of which 26 studies involved alpha-1 antitrypsin augmentation and 17 concerned surgical treatments (largely transplantation). Studies were grouped into four management themes: COPD medical, COPD surgical, AATD specific, and other treatments. Computed tomography (CT) density, forced expiratory volume in 1 s, diffusing capacity of the lungs for carbon monoxide, health status, and exacerbation rates were frequently used as outcomes. Meta-analyses were only possible for RCTs of intravenous augmentation, which slowed progression of emphysema measured by CT density change, 0.79 g/L/year versus placebo (P=0.002), and associated with a small increase in exacerbations 0.29/year (P=0.02). Mortality following lung transplant was comparable between AATD- and non-AATD-related COPD. Surgical reduction of lung volume demonstrated inferior outcomes compared with non-AATD-related emphysema.Conclusion: Intravenous augmentation remains the only disease-specific therapy in AATD and there is evidence that this slows decline in emphysema determined by CT density. There is paucity of data around other treatments in AATD. Treatments for usual COPD may not be as efficacious in AATD, and further studies may be required for this disease group. Keywords: alpha-1 antitrypsin deficiency, treatment, emphysema, transplantation" @default.
• W2611412596 created "2017-05-12" @default.
• W2611412596 creator A5004556588 @default.
• W2611412596 creator A5015107938 @default.
• W2611412596 creator A5025053871 @default.
• W2611412596 creator A5031412055 @default.
• W2611412596 creator A5060814192 @default.
• W2611412596 creator A5063027770 @default.
• W2611412596 date "2017-05-01" @default.
• W2611412596 modified "2023-09-24" @default.
• W2611412596 title "Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review" @default.
• W2611412596 cites W102357629 @default.
• W2611412596 cites W1526181706 @default.
• W2611412596 cites W1691036297 @default.
• W2611412596 cites W1789557997 @default.
• W2611412596 cites W1829394506 @default.
• W2611412596 cites W1887206976 @default.
• W2611412596 cites W1908828006 @default.
• W2611412596 cites W1921725433 @default.
• W2611412596 cites W1953559627 @default.
• W2611412596 cites W1962197481 @default.
• W2611412596 cites W1977335577 @default.
• W2611412596 cites W1980384517 @default.
• W2611412596 cites W1985958848 @default.
• W2611412596 cites W1989921611 @default.
• W2611412596 cites W1994039274 @default.
• W2611412596 cites W1995061321 @default.
• W2611412596 cites W1995228757 @default.
• W2611412596 cites W1997541030 @default.
• W2611412596 cites W1998968284 @default.
• W2611412596 cites W2001164970 @default.
• W2611412596 cites W2002726093 @default.
• W2611412596 cites W2010000248 @default.
• W2611412596 cites W2010618795 @default.
• W2611412596 cites W2010728724 @default.
• W2611412596 cites W2011396394 @default.
• W2611412596 cites W2020859869 @default.
• W2611412596 cites W2024428337 @default.
• W2611412596 cites W2024463504 @default.
• W2611412596 cites W2026206120 @default.
• W2611412596 cites W2027212845 @default.
• W2611412596 cites W2027545901 @default.
• W2611412596 cites W2030201588 @default.
• W2611412596 cites W2030555309 @default.
• W2611412596 cites W2030779919 @default.
• W2611412596 cites W2031945539 @default.
• W2611412596 cites W2039889139 @default.
• W2611412596 cites W2044661074 @default.
• W2611412596 cites W2047195209 @default.
• W2611412596 cites W2064272773 @default.
• W2611412596 cites W2069840901 @default.
• W2611412596 cites W2073346335 @default.
• W2611412596 cites W2074187023 @default.
• W2611412596 cites W2075565532 @default.
• W2611412596 cites W2078854698 @default.
• W2611412596 cites W2079046300 @default.
• W2611412596 cites W2081063734 @default.
• W2611412596 cites W2081169091 @default.
• W2611412596 cites W2082726226 @default.
• W2611412596 cites W2083120544 @default.
• W2611412596 cites W2085035034 @default.
• W2611412596 cites W2094318815 @default.
• W2611412596 cites W2096723137 @default.
• W2611412596 cites W2099430328 @default.
• W2611412596 cites W2100941526 @default.
• W2611412596 cites W2108634930 @default.
• W2611412596 cites W2109981679 @default.
• W2611412596 cites W2110232811 @default.
• W2611412596 cites W2112665587 @default.
• W2611412596 cites W2114163233 @default.
• W2611412596 cites W2117837864 @default.
• W2611412596 cites W2118431328 @default.
• W2611412596 cites W2135677683 @default.
• W2611412596 cites W2142076732 @default.
• W2611412596 cites W2142430815 @default.
• W2611412596 cites W2148670040 @default.
• W2611412596 cites W2149674883 @default.
• W2611412596 cites W2154657665 @default.
• W2611412596 cites W2155981983 @default.
• W2611412596 cites W2156098321 @default.
• W2611412596 cites W2162708373 @default.
• W2611412596 cites W2163696530 @default.
• W2611412596 cites W2171188195 @default.
• W2611412596 cites W2171729350 @default.
• W2611412596 cites W2187206191 @default.
• W2611412596 cites W2251158543 @default.
• W2611412596 cites W2323886210 @default.
• W2611412596 cites W2325223078 @default.
• W2611412596 cites W2334275983 @default.
• W2611412596 cites W2363935454 @default.
• W2611412596 cites W2410628112 @default.
• W2611412596 cites W2414165018 @default.
• W2611412596 cites W2480149274 @default.
• W2611412596 cites W2601839973 @default.
• W2611412596 cites W2798576213 @default.
• W2611412596 cites W2899539709 @default.
• W2611412596 cites W2906992465 @default.
• W2611412596 cites W2915436496 @default.

• next